EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
Recruiting
N/A
Interventional Study
Maternal Sepsis
Infections
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 33,183 (estimated)
- Sponsor
- Columbia University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Sepsis is the second leading cause of maternal death in the U.S. Labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary study is to evaluate a maternal sepsis safety bundle.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Birthing Person (EMR evaluation):
-Delivery hospitalizations and associated postpartum readmissions at the 4 hospital sites between 2020-2025
Exclusion Criteria:
Birthing Person (EMR evaluation)
-Delivery hospitalizations (and associated postpartum readmissions)to a hospital…
Contacts